Browse by subject
Browse by Business Unit
Facilities and collections
More about CSIRO
Avaliable language options:
CSIRO provides a variety of plant gene silencing vectors to educational and research organisations for internal research purposes. If you are an educational or research organisation requiring access for internal research purpose, you can make a request for supply under CSIRO's Material Transfer Agreement.
The Material Transfer Agreement (MTA) is only available for the transfer of the Biological Material to educational and research organisations for internal research purposes.
pHELLSGATE, pWATERGATE, pSTARGATE and pOpOff contain GatewayTM recombination sites. GatewayTM is proprietary technology owned by Invitrogen and to the extent that CSIRO vectors incorporate GatewayTM technology, CSIRO only has permission to distribute these vectors to educational and research organisations for research purposes.
If the Recipient does not satisfy either of these criteria then the Recipient must obtain a separate licence from Invitrogen via this website .
The vector pOpOff also contains the pOp6 promoter for chemically inducible expression of hairpin RNA molecules, contributed by Dr Ian Moore of the University of Oxford. CSIRO only has permission to distribute strictly for non-commercial academic and research purposes.
The Recipient acknowledges that pSTARLING incorporates a maize ubiquitin promoter owned by Dow AgroSciences LLC. CSIRO is unable to grant any rights to the Recipient to use the maize ubiquitin promoter for other than internal research purposes and the Recipient must make separate arrangement with Dow AgroSciences LLC if other uses are intended.
This is an agreement between the Recipient and CSIRO under which CSIRO provides Material for research purposes in accordance with the Terms below. “Agreement” means these Details together with the Terms below.
Other capitalised expressions used in this Agreement not otherwise defined in the Terms have the meanings given to them in these Details.
Commonwealth Scientific and Industrial Research Organisation (ABN 41 687 119 230), having its principal office at Limestone Avenue, Campbell in the Australian Capital Territory, Australia.
Personal Information collected is subject to CSIRO's privacy notice.
1.1 In consideration for the undertakings of the Recipient in this Agreement, CSIRO agrees to provide the
Material to the Recipient solely for the Permitted Use, which is for internal research purposes only at the
laboratories of the Recipient.
1.2 The Recipient represents to CSIRO that the Recipient is primarily a non-profit organisation. The
Recipient may only allow employees to use the Material or derivatives thereof where required for the
Permitted Use and the Recipient is responsible for ensuring those employees comply with the terms
of this Agreement. The Recipient must not distribute the Material or derivatives thereof to any third party.
1.3 All applicable recombinant DNA guidelines must be followed. The Recipient must comply with any
directions given by CSIRO and with all applicable laws and guidelines as to the handling, storage and
disposal of the Material and derivatives thereof. The Recipient must ensure that the Material and
derivatives thereof will be used under suitable containment conditions.
The Material or derivatives thereof must not be used for:
“Subcontractor” means a party who performs a specific part of a research program on behalf and for the benefit of a third party under the supervision and responsibility of such third party.
The Recipient must make the following acknowledgements in any publication concerning or relating to the relevant Material:
4.1 The Recipient’s rights to use the Material are limited to those expressly set out in this Agreement. This
Agreement does not grant any right or option to any commercial licence on the Material. The Recipient
must not attempt to obtain patent coverage or assert any other IP rights over the Material.
4.2 CSIRO makes no representation that the use of the Material will not infringe any IP or other rights of
any person. The Recipient further acknowledges that the Material or elements thereof may be subject to patent rights of CSIRO and/or of third parties.
“IP” means any and all
5.1 THE MATERIAL IS SUPPLIED ON AN “AS IS” BASIS, WHICH MEANS IT MAY HAVE INHERENT
DEFECTS OR DEFICIENCIES. CSIRO DOES NOT GIVE ANY WARRANTY THAT THE MATERIAL IS
SUITABLE FOR THE PERMITTED USE OR ANY OTHER WARRANTY, EXPRESS OR IMPLIED.
5.2 ALL TERMS, CONDITIONS AND WARRANTIES (INCLUDING ANY WARRANTY AS TO
MERCHANTABLE QUALITY OR FITNESS FOR PURPOSE) IMPLIED BY COMMON LAW OR STATUTE
AS TO THE QUALITY OF THE MATERIAL ARE EXCLUDED UNLESS SUCH EXCLUSION WOULD
CONTRAVENE THE LAW OR CAUSE ANY PART OF THIS AGREEMENT TO BE VOID.
5.3 Use of the Material or any part of it is at the Recipient’s own risk. To the maximum extent allowed by law, CSIRO will not be liable to the
Recipient for any damage in any way arising from the Recipient’s use of the Material. The Recipient
releases CSIRO against all claims, actions, demands, suits, liability, loss or expense arising directly or
indirectly from the Recipient’s use of the Material. The Recipient will compensate CSIRO for all damage,
loss or expense (including those incurred in defending or settling any claims, actions or demands)
sustained by CSIRO arising out of the Recipient’s use of the Material and/or breach of this Agreement.
6.1 The Recipient agrees to disclose to CSIRO all information relating to any modifications or
improvements of the Material. The Recipient grants to CSIRO:
6.2 For the avoidance of doubt, CSIRO shall be entitled to:
6.3 Where the Recipient intends to use the Material in research funded by a federal government and is
subject to federal funding laws in the Recipient’s jurisdiction in respect of IP, the Recipient must use its
best endeavours to ensure that CSIRO has access to modifications or improvements of the Material as
contemplated by the Option. This may mean that the Recipient has to elect to retain title to improvements
and modifications. The Material must not be used in research where the Recipient has, prior to entering
into this Agreement with CSIRO, agreed to assign IP to a third party in a way which would prejudice
CSIRO’s rights to negotiate reasonable terms with the Recipient for use of modification or improvements
to the Material as contemplated by the Option.
Without prejudice to any other rights, CSIRO may terminate this Agreement immediately if the Recipient breaches any of its terms. Except if terminated earlier by CSIRO, this Agreement will be valid for a period commencing from the date CSIRO accepts the Recipient’s request for Material under this Agreement and ending on the date of expiry of any valid patent issued and covering the Material.
You confirm you have read and agreed to CSIRO's privacy notice.
The Recipient assures CSIRO that
CSIRO may in its sole discretion refuse to accept this Agreement if the required Details are not provided to CSIRO's satisfaction.
CSIRO reserves the right to reject any request for the Material at its discretion without giving reasons.
This Agreement is governed by the laws of the Australian Capital Territory, Australia.
By submitting your request, you are warranting to CSIRO that:
CSIRO will not accept an MTA which does not include the required information to CSIRO’s satisfaction.
No legal relationship will arise until CSIRO confirms receipt of your submission and notifies you and your organisation that the MTA has been accepted by CSIRO.
Have an enquiry about this page?
Have a question? Contact us using the form below, or call 1300 363 400 during business hours , or start a live chat with us nowor check out our frequent enquiries.
Last updated: Last updated: 25 January 2016
Printed from: Hairpin RNAi vectors for plants - Material Transfer Agreement (http://csiroaucd1-cdc.it.csiro.au/en/Do-business/Collaborative-research/Active-opportunities/RNAi-Material-Transfer-Agreement)